The DOI matches its Crossref record; the references it cites are not checked yet.
Canadian clinical practice guidelines for acute and chronic rhinosinusitis
Open accessAbstract
This document provides healthcare practitioners with information regarding the management of acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) to enable them to better meet the needs of this patient population. These guidelines describe controversies in the management of acute bacterial rhinosinusitis (ABRS) and include recommendations that take into account changes in the bacteriologic landscape. Recent guidelines in ABRS have been released by American and European groups as recently as 2007, but these are either limited in their coverage of the subject of CRS, do not follow an evidence-based strategy, or omit relevant stakeholders in guidelines development, and do not address the particulars of the Canadian healthcare environment.Advances in understanding the pathophysiology of CRS, along with the development of appropriate therapeutic strategies, have improved outcomes for patients with CRS. CRS now affects large numbers of patients globally and primary care practitioners are confronted by this disease on a daily basis. Although initially considered a chronic bacterial infection, CRS is now recognized as having multiple distinct components (eg, infection, inflammation), which have led to changes in therapeutic approaches (eg, increased use of corticosteroids). The role of bacteria in the persistence of chronic infections, and the roles of surgical and medical management are evolving. Although evidence is limited, guidance for managing patients with CRS would help practitioners less experienced in this area offer rational care. It is no longer reasonable to manage CRS as a prolonged version of ARS, but rather, specific therapeutic strategies adapted to pathogenesis must be developed and diffused.Guidelines must take into account all available evidence and incorporate these in an unbiased fashion into management recommendations based on the quality of evidence, therapeutic benefit, and risks incurred. This document is focused on readability rather than completeness, yet covers relevant information, offers summaries of areas where considerable evidence exists, and provides recommendations with an assessment of strength of the evidence base and degree of endorsement by the multidisciplinary expert group preparing the document.These guidelines have been copublished in both Allergy, Asthma & Clinical Immunology and the Journal of Otolaryngology-Head and Neck Surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Viral rhinitis typically manifests in an acute form, and accounts for up to 98% of infectious rhinitis in the young child.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The incidence of viral rhinitis in young children is 6 episodes per patient-year.136”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [136]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 252 · Cited by 313
Research works printed but not linked: 4
- IMS Health: Canadian Disease and Therapeutic Index (CDTI) database. 2006
- Green K, Pong-Porter S: Trends in antimicrobial prescribing and pneumococcal resistance, Canada, 1993-2005. 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco. 2006
- Green K, McGreer A: Trends in antimicrobial resistance in Canadian strains of Streptococcus pneumoniae, 1988-2003. 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago. 2003
- Canadian Pharmacists Association: Compendium of pharmaceuticals and specialties. The Canadian drug reference for health professionals. 2007, Ottawa: Canadian Pharmacists Association
Metadata
- Authors
- Desrosiers, M., Evans, G. A., Keith, P. K., Wright, E. D., Kaplan, A., Bouchard, J., Ciavarella, A., Doyle, P. W., Javer, A. R., Leith, E. S., Mukherji, A., Schellenberg, R. R., Small, P., & Witterick, I. J.
- Affiliations
- Montreal General Hospital (CA)
- Queen's University (CA)
- McMaster University (CA)
- University of Alberta (CA)
- Brampton Civic Hospital (CA)
- Université Laval (CA)
- University of British Columbia (CA)
- University of Toronto (CA)
- Hamilton General Hospital (CA)
- Jewish General Hospital (CA)
- Corresponding author
- Desrosiers, Martin
- ORCID
- Venue
- Allergy, Asthma & Clinical Immunology
- Published
- 2011-02-10
- Volume
- 7
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1710-1484 (ISSN-L)
- 1710-1492
- PMC
- PMC3055847
- OpenAlex
- W2164959292
- Cited by
- 313
- References
- 252
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 10 · 2023: 17 · 2022: 13 · 2021: 18 · 2020: 20 · 2019: 20 · 2018: 29 · 2017: 28 · 2016: 28 · 2015: 35 · 2014: 27 · 2013: 28 · 2012: 15
- FWCI
- 21.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Allergy Asthma and Clinical Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (publishedVersion)
- TSpace (University of Toronto) (acceptedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- Funders
- GlaxoSmithKline
- Sanofi
- Canadian Association of Emergency Physicians
- Association of Medical Microbiology and Infectious Disease Canada
- Merck Canada
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- acute sinusitis, chronic rhinosinusitis, acute bacterial rhinosinusitis, corticosteroids, sinus surgery, primary care management, evidence-based recommendations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Canadian clinical practice guidelines for acute and chronic rhinosinusitis. https://app.cochat.ai/papers/10.1186/1710-1492-7-2
- The paper
- Desrosiers, M., Evans, G. A., Keith, P. K., Wright, E. D., Kaplan, A., Bouchard, J., Ciavarella, A., Doyle, P. W., Javer, A. R., Leith, E. S., Mukherji, A., Schellenberg, R. R., Small, P., & Witterick, I. J. (2011). Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy, Asthma & Clinical Immunology. https://doi.org/10.1186/1710-1492-7-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

![Figure 2 Trends in Antimicrobial Resistance in Canada [58,59]](/paper-figures/e726af192d6a432e8ad514b1b8ad61af/canadian-clinical-practice-guidelines-for-acute-and-chronic-rhinosinusitis-figure-2.jpg)
